Bio Medica Laboratories IPO is to open on May 21, 2026. It is an SME IPO that will raise ₹52.43 crores. The Bio Medica Laboratories IPO price band is fixed at ₹132 to ₹139 with a market lot of 2,000 Shares.
Bio Medica Laboratories IPO GMP Live Rates day by day.
| Date | IPO GMP | GMP Trend | Gain |
| 29 May | ₹- | – | -% |
| 28 May | ₹- | – | -% |
| 27 May | ₹- | – | -% |
| 26 May | ₹- | – | -% |
| 25 May | ₹- | – | -% |
| 23 May | ₹- | – | -% |
| 22 May | ₹2 |  | 1.44% |
| 21 May | ₹- | – | -% |
| 20 May | ₹- | – | -% |
| 19 May | ₹- | – | -% |
| 18 May | ₹- | – | -% |
| 16 May | ₹- | – | -% |
| 15 May | ₹- | – | -% |
| 14 May | ₹- | – | -% |
Bio Medica Laboratories IPO Details
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹132 to ₹139 Per Share |
| Issue Size | Approx ₹52.43 Crores, 37,72,000 Equity Shares |
| Fresh Issue | Approx ₹47.19 Crores, 33,95,000 Equity Shares |
| Offer for Sale: | Approx ₹5.24 Crores, 3,77,000 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Bio Medica Laboratories IPO Dates
| IPO Open Date: | May 21, 2026 |
| IPO Close Date: | May 25, 2026 |
| Basis of Allotment: | May 26, 2026 |
| Refunds: | May 27, 2026 |
| Credit to Demat Account: | May 27, 2026 |
| IPO Listing Date: | May 29, 2026 |
| IPO Bidding Cut-off Time: | May 25, 2026 – 5 PM |
Business Overview
Bio Medica Laboratories is one of the leading manufacturers of parenteral medicines (injectable products) in India. The firm has been involved in developing a wide range of parenteral medicines targeting both human and animal needs. They manufacture generic medicines in the form of Liquid injections and dry powder injections, which come in various forms of packaging like ampoules and vials.
The company also claims to offer high-quality and safe products, followed by Good Manufacturing Practices (GMP and GLP). Moreover, the company has built a reputation for providing reliable yet effective solutions in the healthcare industry. Its product range includes injectables for the domestic market, Injectables for export, and Injectables for veterinary.
Bio Medica Laboratories IPO GMP aka Grey Market Premium FAQs:
What is Bio Medica Laboratories IPO GMP Today?
What is Bio Medica Laboratories IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Bio Medica Laboratories IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
